NIH-funded research R01 grant

Visualizing how morphogens shape fetal development in human cells

Official title: Visualization of extracellular morphogens to understand self-organized patterning

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11526910 · Data updated 2026-11-12

Researchers are studying how key signaling proteins guide early human development using labeled Nodal in stem cells to visualize patterns as cells organize themselves.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 22, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$348,300
NIH project number7R01HD112488-03
Project IDNIH-11526910 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals whose conditions relate to early developmental signaling pathways or birth defects, or healthy volunteers donating samples for iPSC work; patients would not be directly recruited through this grant but may benefit from future translational advances.

Less likely to help

This grant is focused on basic science in cell models and does not involve direct patient treatment or immediate clinical care for participants.

What this research studies

This project uses human pluripotent stem cells with CRISPR-tagged Nodal to watch how morphogens move and interact during early development. By combining live imaging and genetic tools, the team aims to see how Nodal and its inhibitors create spatial patterns that influence cell fate. The work connects basic biology to how left-right axes and germ layers form, potentially informing birth defect understanding. Insights could pave the way for better models of human development and disease.

Why it matters

Potential benefit: A clearer picture of how early developmental signals pattern tissues could improve our understanding of birth defects and inform future therapies or preventive strategies.

How similar studies have gone: Previous work using CRISPR-edited stem cells and live imaging has revealed dynamic morphogen signaling, suggesting this approach can yield meaningful insights in human developmental biology.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Warmflash, Aryeh — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Warmflash, Aryeh

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.